Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8BUD0

Entry ID Method Resolution Chain Position Source
AF-Q8BUD0-F1 Predicted AlphaFoldDB

21 variants for Q8BUD0

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3397725154 39 L>Q No EVA
rs3397823387 41 L>V No EVA
rs3388885090 43 A>T No EVA
rs50856742 51 H>R No EVA
rs3388844186 58 L>Q No EVA
rs3397648408 92 C>Y No EVA
rs3388844156 95 F>S No EVA
rs3397713508 100 Y>H No EVA
rs31773527 141 S>F No EVA
rs3388858769 174 F>I No EVA
rs3397587701 183 M>T No EVA
rs3388886515 184 N>S No EVA
rs3388844125 224 I>F No EVA
rs3388873683 230 S>N No EVA
rs3388875508 238 C>* No EVA
rs3388875477 268 S>Y No EVA
rs3388885121 301 K>N No EVA
rs3388878371 305 N>D No EVA
rs3388880332 306 L>P No EVA
rs3388877111 336 T>I No EVA
rs3388867747 343 V>L No EVA

1 associated diseases with Q8BUD0

Without disease ID

2 regional properties for Q8BUD0

Type Name Position InterPro Accession
repeat GTF2I-like repeat 98 - 192 IPR004212-1
repeat GTF2I-like repeat 323 - 417 IPR004212-2

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

1 GO annotations of molecular function

Name Definition
G protein-coupled receptor activity Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.

12 GO annotations of biological process

Name Definition
adenylate cyclase-activating G protein-coupled receptor signaling pathway A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of adenylyl cyclase activity and a subsequent increase in the intracellular concentration of cyclic AMP (cAMP).
angiogenesis involved in wound healing Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to a damaged tissue, following an injury.
G protein-coupled receptor signaling pathway The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane.
glomerular mesangial cell development The process whose specific outcome is the progression of a glomerular mesangial cell in the kidney over time, from its formation to the mature structure.
negative regulation of angiogenesis Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
phospholipase C-activating G protein-coupled receptor signaling pathway A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of phospholipase C (PLC) and a subsequent increase in the intracellular concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG).
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway Any process that increases the concentration of calcium ions in the cytosol that occurs as part of a PLC-activating G protein-coupled receptor signaling pathway. G-protein-activated PLC hydrolyses phosphatidylinositol-bisphosphate (PIP2) to release diacylglycerol (DAG) and inositol trisphosphate (IP3). IP3 then binds to calcium release channels in the endoplasmic reticulum (ER) to trigger calcium ion release into the cytosol.
positive regulation of inflammatory response Any process that activates or increases the frequency, rate or extent of the inflammatory response.
positive regulation of Rho protein signal transduction Any process that activates or increases the frequency, rate or extent of Rho protein signal transduction.
regulation of cell adhesion Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix.
regulation of vascular permeability Any process that modulates the extent to which blood vessels can be pervaded by fluid.
response to acidic pH Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus with pH < 7. pH is a measure of the acidity or basicity of an aqueous solution.

7 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q1JQB3 GPR4 G-protein coupled receptor 4 Bos taurus (Bovine) PR
O46685 GPR68 Ovarian cancer G-protein coupled receptor 1 Bos taurus (Bovine) PR
P46093 GPR4 G-protein coupled receptor 4 Homo sapiens (Human) PR
Q8BYC4 Gpr20 G-protein coupled receptor 20 Mus musculus (Mouse) PR
Q8BFQ3 Gpr68 Ovarian cancer G-protein coupled receptor 1 Mus musculus (Mouse) PR
P50132 GPR4 G-protein coupled receptor 4 Sus scrofa (Pig) PR
Q4KLH9 Gpr4 G-protein coupled receptor 4 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MDNSTGTGEG CHVDSRVDHL FPPSLYIFVI GVGLPTNCLA LWAAYRQVRQ HNELGVYLMN
70 80 90 100 110 120
LSIADLLYIC TLPLWVDYFL HHDNWIHGPG SCKLFGFIFY SNIYISIAFL CCISVDRYLA
130 140 150 160 170 180
VAHPLRFARL RRVKTAVAVS SVVWATELGA NSAPLFHDEL FRDRYNHTFC FEKFPMERWV
190 200 210 220 230 240
AWMNLYRVFV GFLFPWALML LCYRGILRAV QSSVSTERQE KVKIKRLALS LIAIVLVCFA
250 260 270 280 290 300
PYHALLLSRS AVYLGRPWDC GFEERVFSAY HSSLAFTSLN CVADPILYCL VNEGARSDVA
310 320 330 340 350 360
KALHNLLRFL ASNKPQEMAN ASLTLETPLT SKRSTTGKSS GAVWAVPPTA QGDQVPLKVL
LPPAQ